Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04796714 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE

Study acronym: APPENDAGE
StatusRecruiting
PhasePhase 4
Started2022-10-03
View on ClinicalTrials.gov ↗

Amendment history

2026-06-08
Study Identification, Study Status, References v2
Primary completion date2024-05-03→2027-05-03
Completion date2024-05-03→2027-05-03
2022-10-13
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Primary completion date2022-11-15→2024-05-03
Completion date2022-11-15→2024-05-03
Start dateestimated 2021-04-15→confirmed 2022-10-03
Study sitesdetails revised at 2 of 2 sites
2021-03-10
Original filing
The APPENDAGE study is a phase 4 multicentre randomized opened clinical trial comparing 2 different antithrombotic strategies following left atrial appendage closure (LAAC) in patients with non valvular atrial fibrillation (AF). The primary objective of the study is to evaluate the efficacy of Aspirin versus Aspirin + Clopidogrel after LAAC by comparing the occurrence of ischemic lesions on cerebrovascular magnetic resonance imaging (MRI) studies.
Trial Details
NCT Number NCT04796714
Lead Sponsor University Hospital, Bordeaux
Conditions Atrial Fibrillation, Atrial Appendage, Anticoagulants, Stroke, Platelet Aggregation Inhibitors
Enrollment 60 participants
Start Date 2022-10-03
Primary Completion 2027-05-03 (estimated)
Study Completion 2027-05-03 (estimated)
Updated on ClinicalTrials.gov 2026-06-10